CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Potential relevance of changes in haematocrit to changes in lipid parameters with empagliflozin in patients with type 2 diabetes
DOI 10.1055/s-0036-1580882
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSS Lund, N Sattar, A Salsali, S Crowe, UC Broedl, HN Ginsberg
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: Empagliflozin consistently reduces HbA1c in patients with type 2 diabetes (T2DM) and changes in lipids have been observed. To test our hypothesis that changes in lipids could be partly due to haemoconcentration resulting from increased urinary volume and subsequent volume contraction with empagliflozin, we analysed potential contributions of changes in haematocrit, a marker of changes in plasma volume, to…
Zitieren
Zitierempfehlung
SS Lund, N Sattar, A Salsali, S Crowe, UC Broedl, HN Ginsberg (2016) Potential relevance of changes in haematocrit to changes in lipid parameters with empagliflozin in patients with type 2 diabetes. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0036-1580882
Mit CareLit weiterarbeiten